⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9340036 | 0.75 | — | — | |
| SCHEMBL27924710 | 0.72 | CYP2C19 (0.45) | — | |
| SCHEMBL276169 | 0.72 | — | — | |
| SCHEMBL9340003 | 0.71 | — | — | |
| SCHEMBL16626836 | 0.69 | — | — | |
| SCHEMBL4095064 | 0.69 | — | — | |
| Fluoride SCHEMBL15416673 | 0.69 | — | — | |
| SCHEMBL17227553 | 0.67 | — | — | |
| SCHEMBL497317 | 0.67 | — | — | |
| SCHEMBL15987072 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5270308-A | Hypotensives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-12-14 | — | — | US | claimed |
| US-5112972-A | Cardiovascular disorders as hypotensive agents, angina pectoris | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-05-12 | — | — | US | claimed |
| EP-0477789-A1 | 1,3-Benzoxazine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| EP-3307265-B1 | PHARMACEUTICAL COMBINATION AND USES THEREOF | BIONOMICS LTD (AU) | 2023-12-13 | — | — | EP | disclosed |
| US-10954231-B2 | Anxiolytic compounds | BIONOMICS LIMITED (AU) | 2021-03-23 | — | — | US | disclosed |
| US-20210069147-A1 | PHARMACEUTICAL COMBINATION AND USES THEREOF | BIONOMICS LIMITED (AU) | 2021-03-11 | — | — | US | disclosed |
| US-10564162-B2 | Predictive biomarkers | BIONOMICS LIMITED (AU) | 2020-02-18 | — | — | US | disclosed |
| US-10520508-B2 | Predictive baseline biomarkers for use of vascular disrupting agents | BIONOMICS LIMITED (AU) | 2019-12-31 | — | — | US | disclosed |
| EP-3164717-B1 | PREDICTIVE BIOMARKERS | BIONOMICS LTD (AU) | 2019-08-28 | — | — | EP | disclosed |
| US-10233181-B2 | Anxiolytic compounds | BIONOMICS LIMITED (AU) | 2019-03-19 | — | — | US | disclosed |
| US-10159659-B2 | Predicting response to cancer therapy | BIONOMICS LIMITED (AU) | 2018-12-25 | — | — | US | disclosed |
| EP-0415065-A1 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1991-03-06 | — | — | EP | disclosed |
| EP-0410208-A1 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1991-01-30 | — | — | EP | disclosed |
| EP-0406656-A1 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1991-01-09 | — | — | EP | disclosed |
| EP-0400430-A2 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1990-12-05 | — | — | EP | disclosed |
| EP-0371312-A1 | Benzoxazine derivatives | MERCK PATENT GmbH (DE) | 1990-06-06 | — | — | EP | disclosed |
| EP-0368160-A1 | Tetralin derivatives | MERCK PATENT GmbH (DE) | 1990-05-16 | — | — | EP | disclosed |
| EP-0363883-A1 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1990-04-18 | — | — | EP | disclosed |
| EP-0340718-A1 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1989-11-08 | — | — | EP | disclosed |
| EP-0273262-A2 | Chroman derivatives | MERCK PATENT GmbH (DE) | 1988-07-06 | — | — | EP | disclosed |